Oppenheimer Raises Its Prognosis For The Medicines Company By: Benzinga via Benzinga November 30, 2017 at 12:59 PM EST The Medicines Company (NASDAQ: MDCO) announced Wednesday an agreement to sell its infectious disease business unit to Melinta ... Read More >> Related Stocks: Medicines Company Melinta Therapeutics Inc